Practice for the MRCP(UK) Part 2 Written examination — long-stem, management-focused best-of-five questions with adaptive AI question selection, spaced repetition and per-distractor rationales on every question.
A growing, referenced question bank — NICE, BNF and UK specialty guidance at management depth
📚 Every answer anchored to named guidelines — see something off? Write us and we answer with the reference.
MRCP(UK) Part 2 Written is the second component of the MRCP(UK) Diploma, administered by the Federation of the Royal Colleges of Physicians of the United Kingdom. It tests whether you can apply medical knowledge to real clinical decisions — the diagnosis is often given or nearly given, and the question is what to do next.
The format is 200 best-of-five questions over two 100-question papers of three hours each, on the same day. Stems are longer than Part 1, frequently include several investigation results and an evolving clinical course, and a substantial share carry images — ECGs, chest radiographs, cross-sectional imaging, dermatology photographs, blood films and fundal photographs.
Results are reported on an equated (scaled) score with a published pass mark of 454. There is no negative marking, so every question should be attempted. Eligibility requires a Part 1 pass, and the Diploma's components must be completed within the Federation's validity rules.
Sittings run several times a year at computer-based test centres. Fees, dates and regulations are published on the official website — always confirm current details at mrcpuk.org before applying.
200 management-focused best-of-five questions across two 3-hour papers in a single day.
Prerequisite: A pass in MRCP(UK) Part 1 is required before sitting Part 2 Written.
Validity rules: The Diploma's components must be completed within the Federation's time and attempt regulations — plan your sittings against the published calendar.
Registration Steps:
Source: mrcpuk.org. Verify details before registering.
The Federation does not publish a separate Part 2 weighting — the paper samples the same specialty list as Part 1 (distribution shown) with a stronger management emphasis. AiMedQs mirrors that balance.
Heart failure phenotypes and modern therapy, anticoagulation in complex scenarios, inherited arrhythmias, ECG-based decisions
Severe asthma biologic selection, interstitial lung disease and antifibrotics, pulmonary hypertension, lung cancer pathways
IBD biologic sequencing, decompensated cirrhosis, acute liver failure and transplant criteria, HCC surveillance
Inpatient diabetes care, Cushing's confirmatory testing, adrenal incidentaloma, newer diabetes and obesity therapies
Glomerulonephritis treatment, rapidly progressive GN, renal replacement choices, transplant immunosuppression and its infections
Stroke thrombolysis and thrombectomy decisions, MS disease-modifying therapy, status epilepticus, neuromuscular emergencies
HIV therapy and opportunistic infection, endocarditis by organism and valve, sepsis management, returning-traveller workup
Biologic ladders in RA, vasculitis subtype-specific therapy, lupus nephritis induction, connective tissue disease with organ involvement
Therapy choice under comorbidity constraints, adverse effects of advanced therapies, toxicology management
Leukaemia and lymphoma management, myeloma regimens, VTE decisions in cancer, TTP recognition and treatment
Oncological emergencies, immunotherapy adverse events, end-of-life symptom control
Image-based recognition of bullous disease, severe drug reactions and skin signs of systemic disease
Refractory depression, clozapine care, delirium, falls and bone protection, structured medication review in older people
Part 2 Written is the second of three components. The full MRCP(UK) Diploma runs:
For the most current pathway requirements, visit mrcpuk.org and jrcptb.org.uk.
An intelligent study platform built for the Federation's management-focused written examination.
Questions written the way the real paper reads — evolving presentations, multiple investigation results, and a management pivot where every option is plausible.
NHS framing throughout — SI units with reference ranges, rINN drug names, and treatment sequences as they are actually funded and practised in the UK.
Our engine identifies your weakest specialties and prioritises questions there, so your study time goes where the marks are.
Advanced-therapy answers track NICE guidance and Technology Appraisals; prescribing follows the BNF — the same anchors the examiners use.
Every answer is anchored to a named guideline or standard reference. See something off? Write us and we answer with the reference.
Part 2 distractors are all plausible — so every option gets its own explanation of exactly why it is not the best answer here.
Missed questions return at scientifically optimised intervals, so management sequences hold until exam day.
MRCP(UK) Part 2 tests management as it is practised and funded in the NHS. Generic international question banks miss these critical differences:
Biologic and advanced-therapy answers follow NICE guidance and TAs — the NHS-funded option for the scenario, not simply the newest agent on the market.
Drug and dose answers follow the BNF with rINN names — adrenaline not epinephrine, paracetamol not acetaminophen — and UK monitoring requirements.
Glucose in mmol/L, creatinine in µmol/L, high-sensitivity troponin in ng/L — long stems supply several UK-range results and expect fluent SI-unit reasoning.
Thrombolysis and thrombectomy criteria, transplant referral thresholds, GMC Good Medical Practice and the Mental Capacity Act frame the decision points.
AiMedQs Part 2 questions are written for the UK context at management depth — NICE and BNF-anchored, in SI units, with named references — so your preparation matches the real paper.
Start free. Upgrade when you're ready.
MRCP(UK) Part 2 Written is the second component of the MRCP(UK) Diploma, run by the Federation of the Royal Colleges of Physicians of the United Kingdom. Where Part 1 emphasises knowledge and mechanisms, Part 2 tests the application of that knowledge to clinical management — interpreting evolving presentations, investigation results and images, and choosing the most appropriate next step.
The exam consists of 200 best-of-five questions delivered as two papers of 100 questions, each lasting three hours, sat on the same day. Stems are longer than Part 1 — often with multiple investigation results and a clinical course that evolves — and a substantial share of questions include images such as ECGs, radiographs, CT and MRI, dermatology photographs, blood films and fundal images. There is no negative marking.
Results are reported on an equated (scaled) score, and the published pass mark is 454 on that scale. Equating means the standard stays constant even as individual papers vary in difficulty. Always confirm current scoring arrangements on the official MRCP(UK) website before you sit.
Three shifts define Part 2: stems are longer and richer (8–15 lines with several results, versus 4–8 in Part 1); the pivot moves from diagnosis and mechanism towards management — the most common question is the most appropriate next step; and images become a routine part of the paper. All five options are typically plausible, with the best answer distinguished by a single detail in the stem such as a comorbidity, a drug already taken, or a guideline contraindication.
The Federation does not publish a separate specialty weighting for Part 2 — the paper samples the same internal-medicine specialty list as Part 1, with a stronger management emphasis. In practice that means the eight major specialties (cardiology, endocrinology, gastroenterology, infectious diseases, neurology, renal, respiratory and rheumatology) dominate, alongside clinical pharmacology, haematology, oncology, dermatology, psychiatry and geriatric medicine.
Part 2 is where advanced-therapy decisions appear — which biologic for refractory asthma, which agent for rheumatoid arthritis after methotrexate failure, which DMT for active multiple sclerosis. In the NHS these choices are governed by NICE guidance and Technology Appraisals, so the keyed answer is the NICE-supported option for the scenario, not simply the newest drug. AiMedQs anchors these answers to the named guidance.
Candidates must have passed MRCP(UK) Part 1 before taking Part 2 Written. The components of the Diploma also need to be completed within the Federation's validity rules, so check the current regulations and exam calendar at mrcpuk.org when planning your attempts.
AiMedQs provides a growing, referenced Part 2 question bank built around long, management-focused stems in the exam's best-of-five format, with adaptive AI question selection, spaced repetition, per-distractor rationales and performance analytics by specialty. Every answer is anchored to a named guideline — if you think a keyed answer is wrong, write to us and we answer with the reference.
The Part 2 Written bank is new and growing, with referenced questions added continually. We deliberately publish carefully sourced questions rather than inflating the count — every question carries a named guideline reference and per-distractor explanations.
The final component of the MRCP(UK) Diploma is PACES — the Practical Assessment of Clinical Examination Skills. Completing Part 1, Part 2 Written and PACES earns the MRCP(UK) Diploma, the standard gateway to higher specialty training in medicine in the UK and a widely recognised postgraduate qualification internationally.
Management-focused practice questions with named-guideline references and full rationales. AI-powered. Start studying today.
Try 30 Questions FreeAiMedQs is an exam preparation tool and does not guarantee exam results. Content is for educational purposes only. AiMedQs is not affiliated with or endorsed by the Federation of the Royal Colleges of Physicians of the United Kingdom or MRCP(UK). For official exam information, visit mrcpuk.org.